We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+24.81%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$18.7B
AUM Growth
+$4.8B
(+35%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,702
New
548
Increased
855
Reduced
264
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$140M |
| 2 |
Microsoft
MSFT
|
+$124M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Carrier Global
CARR
|
+$94.7M |
| 5 |
Otis Worldwide
OTIS
|
+$88.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$47.8M |
| 2 |
Abbott
ABT
|
+$25.1M |
| 3 |
Colgate-Palmolive
CL
|
+$24.3M |
| 4 |
Hormel Foods
HRL
|
+$23.2M |
| 5 |
Walmart Inc
WMT
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.9% |
| 2 | Consumer Discretionary | 13.41% |
| 3 | Industrials | 11.79% |
| 4 | Financials | 10.2% |
| 5 | Healthcare | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
CRISPR Therapeutics
CRSP
$4.58B
| $717K | ﹤0.01% |
9,751
+1,556
| +19% | +$91K |
|
802
Cognex
CGNX
$10.3B
| $715K | ﹤0.01% |
11,966
+5,130
| +75% | +$279K |
|
803
Qualys
QLYS
$4.84B
| $712K | ﹤0.01% |
6,847
+4,342
| +173% | +$455K |
|
804
Charles River Laboratories
CRL
$10.9B
| $711K | ﹤0.01% |
4,079
+1,391
| +52% | +$222K |
|
805
Entegris
ENTG
$19.7B
| $708K | ﹤0.01% |
11,989
+1,378
| +13% | +$76.5K |
|
806
First Solar
FSLR
$21.8B
| $708K | ﹤0.01% |
14,305
+6,234
| +77% | +$278K |
|
807
Texas Roadhouse
TXRH
$12.7B
| $707K | ﹤0.01% |
13,455
+6,939
| +106% | +$338K |
|
|
EFOR
808
Everforth Inc
EFOR
$845M
| $706K | ﹤0.01% |
+10,591
| New | +$562K |
|
809
East-West Bancorp
EWBC
$17.9B
| $706K | ﹤0.01% |
19,468
+4,861
| +33% | +$162K |
|
810
Zai Lab
ZLAB
$2.17B
| $703K | ﹤0.01% |
8,562
+3,438
| +67% | +$233K |
|
|
RETA
811
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $702K | ﹤0.01% |
4,500
-616
| -12% | -$93.6K |
|
812
Blackbaud
BLKB
$1.5B
| $701K | ﹤0.01% |
12,285
+5,773
| +89% | +$317K |
|
|
KRTX
813
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $700K | ﹤0.01% |
6,282
+2,083
| +50% | +$181K |
|
814
Lumentum
LITE
$59.4B
| $698K | ﹤0.01% |
8,570
-1,744
| -17% | -$133K |
|
815
American Airlines Group
AAL
$9.58B
| $696K | ﹤0.01% |
53,231
-257,899
| -83% | -$3.13M |
|
|
BLUE
816
DELISTED
bluebird bio
BLUE
| $695K | ﹤0.01% |
879
+213
| +32% | +$161K |
|
817
Neogen
NEOG
$2.05B
| $691K | ﹤0.01% |
17,822
+8,156
| +84% | +$276K |
|
|
SRC
818
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $691K | ﹤0.01% |
19,834
+4,766
| +32% | +$144K |
|
819
Molson Coors Class B
TAP
$7.68B
| $688K | ﹤0.01% |
20,017
+3,415
| +21% | +$136K |
|
820
Live Nation Entertainment
LYV
$41.2B
| $687K | ﹤0.01% |
15,507
+2,681
| +21% | +$118K |
|
|
AMTD
821
DELISTED
TD Ameritrade Holding Corp
AMTD
| $687K | ﹤0.01% |
18,894
+2,107
| +13% | +$79.3K |
|
822
Pacira BioSciences
PCRX
$1.02B
| $685K | ﹤0.01% |
13,056
+4,237
| +48% | +$177K |
|
823
Strategic Education
STRA
$1.71B
| $685K | ﹤0.01% |
4,458
+2,853
| +178% | +$445K |
|
|
RALS
824
DELISTED
ProShares RAFI Long/Short
RALS
| $682K | ﹤0.01% |
21,972
-775
| -3% | -$24.5K |
|
825
Caesars Entertainment
CZR
$6.1B
| $681K | ﹤0.01% |
+16,996
| New | +$471K |
|
Similar funds
ProShare Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, ProShare Advisors held 1,702 positions worth $18.7B, up 35% from $13.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ProShare Advisors deployed $1.69B of net new capital in Q2 2020, opening 548 new positions and adding to 855 existing holdings. Its largest new stake was Carrier Global: 5,097,223 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Clorox, an estimated $47.8M trimmed.
- ProShare Advisors's largest Q2 2020 buy was Carrier Global: 5,097,223 shares worth $113M.
- ProShare Advisors added most to Amazon in Q2 2020, an estimated $140M increase.
- ProShare Advisors's biggest Q2 2020 reduction was Clorox, cutting an estimated $47.8M.
- ProShare Advisors fully exited Utah Medical Products in Q2 2020, selling an estimated $11.6M.
- ProShare Advisors's ten largest holdings make up 24% of its $18.7B portfolio in Q2 2020.
- ProShare Advisors opened 548 new positions and closed 34 in Q2 2020.
- ProShare Advisors's portfolio value rose 35% quarter-over-quarter to $18.7B.
Based on ProShare Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.